WO2010037753A1 - New controlled release active agent carrier - Google Patents

New controlled release active agent carrier Download PDF

Info

Publication number
WO2010037753A1
WO2010037753A1 PCT/EP2009/062633 EP2009062633W WO2010037753A1 WO 2010037753 A1 WO2010037753 A1 WO 2010037753A1 EP 2009062633 W EP2009062633 W EP 2009062633W WO 2010037753 A1 WO2010037753 A1 WO 2010037753A1
Authority
WO
WIPO (PCT)
Prior art keywords
calcium carbonate
reacted
carrier according
natural
carrier
Prior art date
Application number
PCT/EP2009/062633
Other languages
French (fr)
Inventor
Patrick A. C. Gane
Joachim Schölkopf
Original Assignee
Omya Development Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Development Ag filed Critical Omya Development Ag
Priority to US12/998,060 priority Critical patent/US9744107B2/en
Priority to EP09817294A priority patent/EP2331073A1/en
Priority to JP2011529537A priority patent/JP2012504577A/en
Priority to RU2011117358/15A priority patent/RU2502506C2/en
Priority to AU2009299882A priority patent/AU2009299882B2/en
Priority to CA2737395A priority patent/CA2737395A1/en
Priority to CN200980138343.1A priority patent/CN102170867B/en
Publication of WO2010037753A1 publication Critical patent/WO2010037753A1/en
Priority to US14/970,746 priority patent/US9757314B2/en
Priority to US15/646,657 priority patent/US10045919B2/en
Priority to US15/671,620 priority patent/US10137066B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Definitions

  • the present invention relates to a carrier for the controlled release of active agents, a method of its preparation, and its uses.
  • Controlled release formulations are generally known in the art, especially with respect to pharmaceutical formulations. Such preparations are e.g. formulated to dissolve slowly and release a drug over time. The advantages of such sustained- release tablets or capsules are that they can be taken less frequently than instant- release formulations of the same drug, and that they keep levels of the drug steadier in the bloodstream. Sustained-release tablets are formulated so that the active ingredient is typically embedded in a matrix of insoluble substance, such as e.g. polyacrylic acids, so that the dissolving drug has to find its way out through the holes in the matrix.
  • insoluble substance such as e.g. polyacrylic acids
  • Controlled release can also mean immediate release under certain conditions, e.g. depending on the pH or the milieu at the destination environment.
  • formulations are often coated with polymeric substances in order to ensure the release of active agent at the desired target environment.
  • a typical example therefor are formulations for the oral administration being coated with a acid resistant, but alkali soluble coating, in order to ensure the passage through the stomach without loss of the active agent, and the subsequent slow or immediate release of the agent in the alkaline intestinal environment.
  • Controlled release formulations in the pharmaceutical field ideally are useful for various ways of administration, e.g.:
  • controlled release formulations are also interesting in other fields, such as in agricultural, biological, cosmetic or any other technical applications, where it is important that the active agent is released at a specific target environment and is not released unless this environment is reached.
  • a carrier for the controlled release of active agents comprising:
  • Preferred synthetic calcium carbonate is precipitated calcium carbonate comprising aragonitic, vateritic or calcitic mineralogical crystal forms or mixtures thereof.
  • the natural calcium carbonate is selected from the group comprising marble, chalk, calcite, dolomite, limestone and mixtures thereof.
  • the natural or synthetic calcium carbonate is ground prior to the treatment with one or more acids and carbon dioxide.
  • the grinding step can be carried out with any conventional grinding device such as a grinding mill known to the skilled person.
  • the surface-reacted natural or synthetic calcium carbonate to be used in the present invention is prepared as an aqueous suspension having a pH, measured at 20 0 C, of greater than 6.0, preferably greater than 6.5, more preferably greater than 7.0, even more preferably greater than 7.5.
  • the natural and synthetic calcium carbonate is suspended in water.
  • the slurry has a content of natural or synthetic calcium carbonate within the range of 1 wt-% to 80 wt-%, more preferably 3 wt-% to 60 wt-%, and even more preferably 5 wt-% to 40 wt-%, based on the weight of the slurry.
  • an acid is added to the aqueous suspension containing the natural or synthetic calcium carbonate.
  • the acid has a pK a at 25°C of 2.5 or less.
  • the acid is preferably selected from sulphuric acid, hydrochloric acid, or mixtures thereof. If the pK a at 25°C is from 0 to 2.5, the acid is preferably selected from H 2 SO 3 , HSO 4 " , H 3 PO 4 , oxalic acid or mixtures thereof.
  • the one or more acids can be added to the suspension as a concentrated solution or a more diluted solution.
  • the molar ratio of the acid to the natural or synthetic calcium carbonate is from 0.05 to 4, more preferably from 0.1 to 2.
  • the natural or synthetic calcium carbonate is treated with carbon dioxide. If a strong acid such as sulphuric acid or hydrochloric acid is used for the acid treatment of the natural or synthetic calcium carbonate, the carbon dioxide is automatically formed. Alternatively or additionally, the carbon dioxide can be supplied from an external source.
  • Acid treatment and treatment with carbon dioxide can be carried out simultaneously which is the case when a strong acid is used. It is also possible to carry out acid treatment first, e.g. with a medium strong acid having a pK a in the range of 0 to 2.5, followed by treatment with carbon dioxide supplied from an external source.
  • the concentration of gaseous carbon dioxide in the suspension is, in terms of volume, such that the ratio (volume of suspension): (volume of gaseous CO 2 ) is from 1 :0.05 to 1:20, even more preferably 1 :0.05 to 1 :5.
  • the acid treatment step and/or the carbon dioxide treatment step are repeated at least once, more preferably several times.
  • the pH of the aqueous suspension measured at 20 0 C, naturally reaches a value of greater than 6.0, preferably greater than 6.5, more preferably greater than 7.0, even more preferably greater than 7.5, thereby preparing the surface-reacted natural or synthetic calcium carbonate as an aqueous suspension having a pH of greater than 6.0, preferably greater than 6.5, more preferably greater than 7.0, even more preferably greater than 7.5. If the aqueous suspension is allowed to reach equilibrium, the pH is greater than 7. A pH of greater than 6.0 can be adjusted without the addition of a base when stirring of the aqueous suspension is continued for a sufficient time period, preferably 1 hour to 10 hours, more preferably 1 to 5 hours.
  • the pH of the aqueous suspension may be increased to a value greater than 6 by adding a base subsequent to carbon dioxide treatment.
  • Any conventional base such as sodium hydroxide or potassium hydroxide can be used.
  • surface-reacted precipitated calcium carbonate is obtained.
  • surface-reacted precipitated calcium carbonate is obtained by contacting precipitated calcium carbonate with H 3 O + ions and with anions being solubilised in an aqueous medium and being capable of forming water-insoluble calcium salts, in an aqueous medium to form a slurry of surface-reacted precipitated calcium carbonate, wherein said surface-reacted precipitated calcium carbonate comprises an insoluble, at least partially crystalline calcium salt of said anion formed on the surface of at least part of the precipitated calcium carbonate.
  • Said solubilised calcium ions correspond to an excess of solubilised calcium ions relative to the solubilised calcium ions naturally generated on dissolution of precipitated calcium carbonate by H 3 O + ions, where said H 3 O + ions are provided solely in the form of a counterion to the anion, i.e. via the addition of the anion in the form of an acid or non-calcium acid salt, and in absence of any further calcium ion or calcium ion generating source.
  • Said excess solubilised calcium ions are preferably provided by the addition of a soluble neutral or acid calcium salt, or by the addition of an acid or a neutral or acid non-calcium salt which generates a soluble neutral or acid calcium salt in situ.
  • Said H 3 O + ions maybe provided by the addition of an acid or an acid salt of said anion, or the addition of an acid or an acid salt which simultaneously serves to provide all or part of said excess solubilised calcium ions.
  • the natural or synthetic calcium carbonate is reacted with the acid and/or the carbon dioxide in the presence of at least one compound selected from the group consisting of silicate, silica, aluminium hydroxide, earth alkali aluminate such as sodium or potassium aluminate, magnesium oxide, or mixtures thereof.
  • the at least one silicate is selected from an aluminium silicate, a calcium silicate, or an earth alkali metal silicate.
  • the silicate and/or silica and/or aluminium hydroxide and/or earth alkali aluminate and/or magnesium oxide component(s) can be added to the aqueous suspension of natural or synthetic calcium carbonate while the reaction of natural or synthetic calcium carbonate with an acid and carbon dioxide has already started. Further details about the preparation of the surface-reacted natural or synthetic calcium carbonate in the presence of at least one silicate and/or silica and/or aluminium hydroxide and/or earth alkali aluminate component(s) are disclosed in WO 2004/083316, the content of this reference herewith being included in the present application.
  • the surface-reacted natural or synthetic calcium carbonate can be kept in suspension, optionally further stabilised by a dispersant.
  • a dispersant Conventional dispersants known to the skilled person can be used.
  • a preferred dispersant is polyacrylic acid.
  • the aqueous suspension described above can be dried, thereby obtaining the solid (i.e. dry or containing as little water that it is not in a fluid form) surface-reacted natural or synthetic calcium carbonate in the form of granules or a powder.
  • the surface-reacted natural or synthetic calcium carbonate has a specific surface area of from 5 m 2 /g to 200 m 2 /g, more preferably 20 m 2 /g to 80 m 2 /g and even more preferably 30 m 2 /g to 60 m 2 /g, measured using nitrogen and the BET method according to ISO 9277.
  • the surface-reacted natural or synthetic calcium carbonate has a weight median grain diameter of from 0.1 to 50 ⁇ m, more preferably from 0.5 to 25 ⁇ m, especially from 0.8 to 20 ⁇ m, most preferably from 1 to 10 ⁇ m, measured according to the sedimentation method.
  • the sedimentation method is an analysis of sedimentation behaviour in a gravimetric field. The measurement is made with a SedigraphTM 5100 of Micromeritics Instrument Corporation. The method and the instrument are known to the skilled person and are commonly used to determine grain size of fillers and pigments. The measurement is carried out in an aqueous solution of 0.1 wt-% Na 4 P 2 O 7 . The samples were dispersed using a high speed stirrer and supersonicated.
  • the surface-reacted natural or synthetic calcium carbonate has a specific surface area within the range of 5 to 200 m 2 /g and a weight median grain diameter within the range of 0.1 to 50 ⁇ m. More preferably, the specific surface area is within the range of 20 to 80 m 2 /g and the weight median grain diameter is within the range of 0.5 to 25 ⁇ m. Even more preferably, the specific surface area is within the range of 30 to 60 m 2 /g and the weight median grain diameter is within the range of 0.7 to 7 ⁇ m.
  • the surface reacted calcium carrier is capable of associating and transporting an active agent.
  • the association preferably is an adsorption onto the surface of the surface-reacted calcium carbonate particles, be it the outer or the inner surface of the particles or an absorption into the particles, which is possible due to their porosity.
  • this material is a superior agent to deliver previously ad/absorbed materials over time relative to common materials having similar specific surface areas.
  • the ad/absorption characteristics can be controlled by the pore size and/or pore volume and/or surface area for a given agent.
  • the surface-reacted natural or synthetic calcium carbonate has an intra- particle porosity within the range of from 5 vol.-% to 50 vol.-%, preferably of from 20 vol.-% to 50 vol.-%, especially of from 30 vol.-% to 50 voL-% calculated from a mercury porosimetry measurement. From the bimodal derivative pore size distribution curve the lowest point between the peaks indicates the diameter where the intra and inter-particle pore volumes can be separated. The pore volume at diameters greater than this diameter is the pore volume associated with the inter- particle pores. The total pore volume minus this inter particle pore volume gives the intra particle pore volume from which the intra particle porosity can be calculated, preferably as a fraction of the solid material volume, as described in Transport in Porous Media (2006) 63: 239-259.
  • the intra-particle porosity determined as the pore volume per unit particle volume is within the range of from 20 vol.-% to 99 vol.-%, preferably from 30 vol.- % to 70 vol.-%, more preferably from 40 vol.-% to 60 vol.-%, e.g. 50 vol.-%.
  • ad/absorption and release of the active agent is essentially controlled by the pore size, which preferably is in a range of from 10 to 100 nm, more preferably in a range of between 20 and 80 nm, especially from 30 to 70 nm, e.g. 50 nm.
  • any agent fitting into the intra- and/or inter particle pores of the surface-reacted calcium carbonate carrier is suitable to be transported by the surface- reacted calcium carbonate carriers according to the invention.
  • any active agent be it for the transport in or into the human or animal body, in agricultural or any other applications, can be useful in the present invention, e.g. agents selected from the group comprising pharmaceutically, biologically, cosmetically active agents, scented agents or flavoring agents, biocides, pesticides or herbicides, and disinfecting agents.
  • active agents such as those selected from the group comprising triclosan, anticarcinogens, limonene, peppermint, surfactants like defoamers, or softeners, mineral oils, silicone, wetting agents, wax, paraffin, hydrolytic agents such as hydrolytic binders, anti-dusting oils, and o-phenylphenol and Bronopol can be used.
  • An especially interesting group of active agents are anticarcinogens, as cancer cells are acidic, and this acidity assists the release of the anticarcinogen at the cancer cells.
  • the carriers having an active agent associated therewith according to the invention can be administered directly via the oral way, via inhalation, and via the dermal tissue as mentioned above. They can even be administered via injection to the body, e.g. intravenously or subcutaneously. If sufficient agent is delivered to the target environment, the present invention may even provide an alternate route to providing agents via vaccination.
  • the surface-reacted calcium carbonate carrier may be combined with one or several further carrier materials, such as for example a chewing gum or tooth paste formulation as regards the oral administration.
  • a tooth paste comprising surface-reacted calcium carbonate as a carrier of, e.g. triclosan, or flavoring agents can be provided.
  • the carrier having the active agent associated therewith can be formulated into common galenical formulations such as oil-based capsules such as vitamin capsules, tablets, creams and the like.
  • the carrier may be combined with, e.g. a nasal spray formulation, transporting pharmaceutically active agents, or odorous substances including scented oils such as limonene or peppermint.
  • Dermal application may be formulated e.g. into a cosmetic formulation which may be applied to the skin or hair.
  • a cosmetic formulation which may be applied to the skin or hair.
  • any kind of cosmetic formulations are suitable such as patches, soaps, creams such as skin creams and sunscreens, foundations, hair care products, perfumes, powders such as foot powders or facial powders, lipsticks, deodorants, or bath additives, e.g. in the form of bath bombs or bath tablets, wherein natural oils such as peppermint oil or amaranth oil may be incorporated.
  • agents reacting with the surface-reacted calcium carbonate such as acidic agents sometimes are not suitable to be transported with the surface-reacted calcium carbonate.
  • acidic agents may be advantageously used, e.g., if the calcium salt of the acidic agent is required or beneficial.
  • a certain level of acidity can also enhance adsorption to the surface of the carrier.
  • the delivery mechanism, following ab/adsorption of the agent onto and/or into the surface-reacted calcium carbonate is essentially based on one or several of the following mechanisms:
  • the association, i.e. ad/absorption of the agent onto and/or into the surface-reacted calcium carbonate carrier is generally effected by contacting the surface reacted calcium carbonate with a solution or suspension of the active agent in a suitable medium, which is preferably water, but can generally be any medium. However, if the medium is acidic, it needs to be weaker than the acid that formed the reacted surface salt and in dilute form. Then it can be exposed to a low pH for a limited time at least.
  • the surface-reacted calcium carbonate may be in the form of a tablet or powder, which after the association is completed is separated from the excess liquid, solution or suspension, e.g. by filtration, and optionally dried.
  • the resulting loaded tablet or powder is applied directly or combined with a second carrier as described above, such as a cream, a tablet, capsule or any other galenical form as described above according to methods well-known in the art.
  • a second carrier such as a cream, a tablet, capsule or any other galenical form as described above according to methods well-known in the art.
  • Figure 1 shows a SEM image of surface-reacted calcium carbonate useful in the present invention
  • Figure 2 shows an apparatus designed and suitable for making surface-reacted calcium carbonate tablets from wet suspensions.
  • Figure 3 shows a schematic cross-section of a die used for compacting powders.
  • Figure 4 shows a graph illustrating the release characteristics of a carrier according to the invention and a comparative sample.
  • Figure 5 shows a graph illustrating the sustained release effect of surface-treated calcium carbonate compared with conventional calcium carbonate
  • the surface-reacted calcium carbonate was prepared in a 100 litre E SCO-reactor.
  • the tablet was made from a suspension of surface-reacted calcium carbonate having a solids content of 30 wt-% ⁇ 5 wt.-%.
  • the tablets were formed by applying a constant pressure to the suspension for several minutes, typically 1-10 min, such that water is released by filtration through a fine 0.025 ⁇ m filter membrane resulting in a compacted tablet of the surface-reacted calcium carbonate.
  • the apparatus used is illustrated in figure 2. It is further described in: Ridgway, C. J., Gane, P. A. C. and Schoelkopf, J., "Modified Calcium Carbonate Coatings with Rapid Absorption and Extensive Liquid Uptake Capacity", Colloids and Surfaces A, 236(1-3), 2004, p. 91- 102.
  • the tablets were removed from the apparatus and dried in an oven at 8O 0 C for 24 hours.
  • silicates used as a reference were products available under the tradename GASIL ® HP39 and PlOl available from INEOS Silicas and had the following characteristics:
  • silicate powders were formed into tablets in the form of blocks by a dry compaction method as follows:
  • a cylindrical hardened steel die attached to a base plate with a single acting upper piston was used which is suitable for a wide range of particle sizes, chemistries and morphologies.
  • the die is divisible into two parts to aid removal of the compacted pigment sample and the walls of the die are protected with a strip of plastic film to prevent sticking of the powder to the wall and to reduce edge friction (Fig. 3).
  • the surface-reacted calcium carbonate tablets which were previously ground to a cubic shape, as well as the silicate blocks were placed in dishes. Limonene (pure or in alcohol/water) was added to the dishes such that the top surfaces of the tablets remained in contact with air (allowing any air in the tablets to escape as limonene is absorbed).
  • the tablets were removed from the dish and allowed to stand in an open environment under standard temperature and pressure conditions until limonene could not be detected by smelling any more (for up to 350 hours). At this point, the tablets were placed in a closed jar and heated in order to analyze the weight of remaining limonene.
  • the quantification was carried out by gas chromatography in a HS TurboMatrix 40
  • Timing Thermo 20.0 min, Delay: 0.8 min, Pressurize 1.0 min, Dry Purge 5.0 min, Desorb. 0.1 min, Trap Hold 5.0 min
  • Example 2 Transport and release of oily substances in an aqueous environment
  • bath bombs and bath tablets were produced with surface-reacted calcium carbonate saturated with scents (natural oils) such as amaranth as well as peppermint oil.
  • scents natural oils
  • the bath bombs or bath tablets were dropped into water at a temperature of 37 °C in order to extract and evaluate the released oil.
  • Citric acid and sodium bicarbonate were provided and well blended manually in a mortar.
  • the colour solutions were added and well mixed.
  • the given amounts of surface-reacted calcium carbonate and amaranth oil were added, either by adding the surface-reacted calcium carbonate saturated with the amaranth oil and manually well mixed (sample 1 and 3), or by adding the components separately (sample 2).
  • witch hazel was sprayed (with a squirt bottle) while stirring manually. As soon as the batch sticks together upon squishing, potions of the bulk are put into a conventional aluminium form.
  • the water phase (pH 6,6 ⁇ 0.2) was discarded; the oil/solvent phase was filled into a 50 ml brown glass bottle and analyzed by determining the weight after evaporation of the solvent.
  • the appearance of the solvent phases is turbid, milky white for the amaranth sample.
  • 34.5 wt-% of surface-reacted calcium carbonate were manually mixed with 10 wt-% amaranth oil in a mortar. The mixture was then added to 54.5 wt-% of a citric acid / sodium bicarbonate mixture (in a weight ratio of 1 : 2) and manually mixed in order to obtain a powdery batch. While squishing manually, 2 wt-% of Hanmamelis water witch hazel was sprayed onto the batch in order to get a sticky powder.
  • tablet structures were formed by using a cylindrical hardened steel die attached to a base plate with a single acting upper piston.
  • the die is divisible into two parts to aid removal of the compacted powder sample and the walls of the die are protected with a strip of plastic film to prevent sticking of the powder to the wall and to reduce edge friction.
  • the powders were covered with a cellulose membrane at the bottom as well as on top before being compacted in a hydraulic press for 1 minute at a predetermined force of 15 kN (an effective pressure of 35 bar).
  • the tablets were formed of 1.5 to 1.8 cm in height and a diameter of 4.8 cm. All tablets were well compacted.
  • the height of the powder in the instrument was approximately 4.5 to 5 cm (the maximum height of the cylindrical steel is 8 cm).
  • Example 3 Transport and release of oily substances in an oily environment
  • Injector 300 0 C 5 Split on Temp.: 22O 0 C 8.0 min Pressure: 70 kPa
  • the pigment / methylbutyl isovalerat mixture was placed in the dish with the hexadecane to one side away from the stirrer. After a certain time period, a sample of the fluid phase was removed for analysis.
  • This process was repeated for increasing lengths of time, each time using a fresh calcium carbonate / methylbutyl isovalerat mixture.
  • Example 4 Further formulations comprising the carrier of the invention
  • the surface-reacted calcium carbonate was prepared in a 5 m 3 reactor.
  • Sorbitol, sodium monofluorophosphate, potassium acesulfam and water were thoroughly mixed together.
  • a non surface reacted calcium carbonate powder / titanium dioxide powder blend was added and wetted therewith.
  • a mixture of surface-reacted calcium carbonate as described above and spearmint aroma, which was dropwise added to the surface reacted calcium carbonate while manually stirring, and, subsequently, cellulose gum were added while stirring in order to obtain a homogenous paste.
  • the paste is further stirred slowly and cooled down to room temperature.
  • sodium lauryl sulphate in water / cocamidopropyl betaine is slowly added while stirring, under vacuum if required.
  • This example describes the loading of an oil in water emulsion into surface-reacted calcium carbonate acting as a carrier in a skin care formulation.
  • the oil itself is loaded into the surface-reacted calcium carbonate, it would be displaced by water as soon as the loaded surface-reacted calcium carbonate is introduced into an aqueous formulation. Subsequently the oil would be visible as floating macroscopic droplets.
  • the surface-reacted calcium carbonate was prepared in a 10 m reactor.
  • an emulsion was prepared. This operation was carried out by using a rotor- stator d ⁇ ssolver from Kinematika, Polytron PT 300 at 10000 min "1 .
  • a rotor- stator d ⁇ ssolver from Kinematika, Polytron PT 300 at 10000 min "1 .
  • 94.031 g of demineralised water was charged with 1.028 g of PEG-40 hydrogenated castor oil and homogenised until the emulsifier is well dissolved.
  • 5.001 g of amaranth oil was added dropwise and dispersed well until a homogeneous milky emulsion was formed.
  • the surface-reacted calcium carbonate was loaded with the resulting emulsion.
  • 15.004 g of surface-reacted calcium carbonate was weighed into a ceramic mortar (0 180 mm) and 20.209 g of the emulsion was added dropwise under mixing with pestle into the surface-reacted calcium carbonate until a white glossy creme was formed.
  • the gel formulation was prepared by mixing 1,2-propanediol, butylene glycol and water, subsequent interspersing under stirring ammonium acryloyldimethyltaurate / VP Copolymer and allowing swelling resulting in a gel. Then, Lauryl PEG/PPG- 18/18 Methicone, PEG- 12 Dimethicone, Shea Blend Emulsion, Silicone Elastomer Suspension, Liposome, non-ionic emulsion and Phenochem were mixed under stirring and added to the gel.
  • the resulting creme had - a pH of ⁇ .94 - a Brookfield viscosity of 23480 mPa-s (Brookfield DV-II (RT; RV 5, 30s/10rpm))

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)

Abstract

The present invention relates to carriers for the controlled release of active agents, comprising surface reacted natural or synthetic calcium carbonate, one or more active agents, wherein said one or more active agent is associated with said surface- reacted calcium carbonate, and wherein said surface-reacted natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source. It further relates to the preparation of loaded carriers, as well as their use in different applications.

Description

NEW CONTROLLED RELEASE ACTIVE AGENT CARRIER
The present invention relates to a carrier for the controlled release of active agents, a method of its preparation, and its uses.
Controlled release formulations are generally known in the art, especially with respect to pharmaceutical formulations. Such preparations are e.g. formulated to dissolve slowly and release a drug over time. The advantages of such sustained- release tablets or capsules are that they can be taken less frequently than instant- release formulations of the same drug, and that they keep levels of the drug steadier in the bloodstream. Sustained-release tablets are formulated so that the active ingredient is typically embedded in a matrix of insoluble substance, such as e.g. polyacrylic acids, so that the dissolving drug has to find its way out through the holes in the matrix.
Controlled release, however, can also mean immediate release under certain conditions, e.g. depending on the pH or the milieu at the destination environment.
Furthermore, such formulations are often coated with polymeric substances in order to ensure the release of active agent at the desired target environment. A typical example therefor are formulations for the oral administration being coated with a acid resistant, but alkali soluble coating, in order to ensure the passage through the stomach without loss of the active agent, and the subsequent slow or immediate release of the agent in the alkaline intestinal environment.
Controlled release formulations in the pharmaceutical field ideally are useful for various ways of administration, e.g.:
- oral application for the delivery of the agent to the intestines, where it is especially important that the agent is protected against the gastric acids while it is transported through the stomach prior to the delivery to the intestines,
- oral application for the delivery of the agent to the oral mucosa, - inhalation of the carrier for delivery of the agent to the blood vessels (veins) lining the nasal passages, or
- dermal application of the carrier onto and through the skin.
However, controlled release formulations are also interesting in other fields, such as in agricultural, biological, cosmetic or any other technical applications, where it is important that the active agent is released at a specific target environment and is not released unless this environment is reached.
In any of such applications, useful controlled release formulation should meet the following requirements:
(i) retention of a sufficient quantity of active agent prior to the release at the target environment (ii) release of a sufficient quantity of active agent at the target environment, and (iii) sufficient protection by the carrier prior to delivery and release at the target environment so that it remains sufficiently active.
As mentioned above, this is usually achieved by complicated matrix or coating formulations involving time- and cost-intensive manufacturing processes.
Thus, there is a continuous need for new carriers allowing a controlled release of an active agent having the above-mentioned characteristics, which are easily available and processed and thus are more favorable than the known ones, not only from an economic point of view.
The above problem has been solved by a carrier for the controlled release of active agents, comprising:
- surface-reacted natural or synthetic calcium carbonate, - one or more active agents, wherein said one or more active agent(s) is (are) associated with said surface-reacted calcium carbonate, and wherein said surface-reacted natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source.
Preferred synthetic calcium carbonate is precipitated calcium carbonate comprising aragonitic, vateritic or calcitic mineralogical crystal forms or mixtures thereof.
Preferably, the natural calcium carbonate is selected from the group comprising marble, chalk, calcite, dolomite, limestone and mixtures thereof.
In a preferred embodiment, the natural or synthetic calcium carbonate is ground prior to the treatment with one or more acids and carbon dioxide. The grinding step can be carried out with any conventional grinding device such as a grinding mill known to the skilled person.
Preferably the surface-reacted natural or synthetic calcium carbonate to be used in the present invention is prepared as an aqueous suspension having a pH, measured at 200C, of greater than 6.0, preferably greater than 6.5, more preferably greater than 7.0, even more preferably greater than 7.5.
In a preferred process for the preparation of the aqueous suspension, the natural and synthetic calcium carbonate, either finely divided, such as by grinding, or not, is suspended in water. Preferably, the slurry has a content of natural or synthetic calcium carbonate within the range of 1 wt-% to 80 wt-%, more preferably 3 wt-% to 60 wt-%, and even more preferably 5 wt-% to 40 wt-%, based on the weight of the slurry. In a next step, an acid is added to the aqueous suspension containing the natural or synthetic calcium carbonate. Preferably, the acid has a pKa at 25°C of 2.5 or less. If the pKa at 25°C is 0 or less, the acid is preferably selected from sulphuric acid, hydrochloric acid, or mixtures thereof. If the pKa at 25°C is from 0 to 2.5, the acid is preferably selected from H2SO3, HSO4 ", H3PO4, oxalic acid or mixtures thereof. The one or more acids can be added to the suspension as a concentrated solution or a more diluted solution. Preferably, the molar ratio of the acid to the natural or synthetic calcium carbonate is from 0.05 to 4, more preferably from 0.1 to 2.
As an alternative, it is also possible to add the acid to the water before the natural or synthetic calcium carbonate is suspended.
In a next step, the natural or synthetic calcium carbonate is treated with carbon dioxide. If a strong acid such as sulphuric acid or hydrochloric acid is used for the acid treatment of the natural or synthetic calcium carbonate, the carbon dioxide is automatically formed. Alternatively or additionally, the carbon dioxide can be supplied from an external source.
Acid treatment and treatment with carbon dioxide can be carried out simultaneously which is the case when a strong acid is used. It is also possible to carry out acid treatment first, e.g. with a medium strong acid having a pKa in the range of 0 to 2.5, followed by treatment with carbon dioxide supplied from an external source.
Preferably, the concentration of gaseous carbon dioxide in the suspension is, in terms of volume, such that the ratio (volume of suspension): (volume of gaseous CO2) is from 1 :0.05 to 1:20, even more preferably 1 :0.05 to 1 :5. In a preferred embodiment, the acid treatment step and/or the carbon dioxide treatment step are repeated at least once, more preferably several times.
Subsequent to the acid treatment and carbon dioxide treatment, the pH of the aqueous suspension, measured at 200C, naturally reaches a value of greater than 6.0, preferably greater than 6.5, more preferably greater than 7.0, even more preferably greater than 7.5, thereby preparing the surface-reacted natural or synthetic calcium carbonate as an aqueous suspension having a pH of greater than 6.0, preferably greater than 6.5, more preferably greater than 7.0, even more preferably greater than 7.5. If the aqueous suspension is allowed to reach equilibrium, the pH is greater than 7. A pH of greater than 6.0 can be adjusted without the addition of a base when stirring of the aqueous suspension is continued for a sufficient time period, preferably 1 hour to 10 hours, more preferably 1 to 5 hours.
Alternatively, prior to reaching equilibrium, which occurs at a pH greater than 7, the pH of the aqueous suspension may be increased to a value greater than 6 by adding a base subsequent to carbon dioxide treatment. Any conventional base such as sodium hydroxide or potassium hydroxide can be used.
Further details about the preparation of the surface-reacted natural calcium carbonate are disclosed in WO 00/39222 and US 2004/0020410 Al, wherein the surface- reacted natural calcium carbonate is described as a filler for paper manufacture, the content of these references herewith being included in the present application.
Similarly, surface-reacted precipitated calcium carbonate is obtained. As can be taken in detail from unpublished European Patent Application No. 07123077, surface-reacted precipitated calcium carbonate is obtained by contacting precipitated calcium carbonate with H3O+ ions and with anions being solubilised in an aqueous medium and being capable of forming water-insoluble calcium salts, in an aqueous medium to form a slurry of surface-reacted precipitated calcium carbonate, wherein said surface-reacted precipitated calcium carbonate comprises an insoluble, at least partially crystalline calcium salt of said anion formed on the surface of at least part of the precipitated calcium carbonate.
Said solubilised calcium ions correspond to an excess of solubilised calcium ions relative to the solubilised calcium ions naturally generated on dissolution of precipitated calcium carbonate by H3O+ ions, where said H3O+ ions are provided solely in the form of a counterion to the anion, i.e. via the addition of the anion in the form of an acid or non-calcium acid salt, and in absence of any further calcium ion or calcium ion generating source.
Said excess solubilised calcium ions are preferably provided by the addition of a soluble neutral or acid calcium salt, or by the addition of an acid or a neutral or acid non-calcium salt which generates a soluble neutral or acid calcium salt in situ.
Said H3O+ ions maybe provided by the addition of an acid or an acid salt of said anion, or the addition of an acid or an acid salt which simultaneously serves to provide all or part of said excess solubilised calcium ions.
In a preferred embodiment of the preparation of the surface-reacted natural or synthetic calcium carbonate, the natural or synthetic calcium carbonate is reacted with the acid and/or the carbon dioxide in the presence of at least one compound selected from the group consisting of silicate, silica, aluminium hydroxide, earth alkali aluminate such as sodium or potassium aluminate, magnesium oxide, or mixtures thereof. Preferably, the at least one silicate is selected from an aluminium silicate, a calcium silicate, or an earth alkali metal silicate. These components can be added to an aqueous suspension comprising the natural or synthetic calcium carbonate before adding the acid and/or carbon dioxide. Alternatively, the silicate and/or silica and/or aluminium hydroxide and/or earth alkali aluminate and/or magnesium oxide component(s) can be added to the aqueous suspension of natural or synthetic calcium carbonate while the reaction of natural or synthetic calcium carbonate with an acid and carbon dioxide has already started. Further details about the preparation of the surface-reacted natural or synthetic calcium carbonate in the presence of at least one silicate and/or silica and/or aluminium hydroxide and/or earth alkali aluminate component(s) are disclosed in WO 2004/083316, the content of this reference herewith being included in the present application.
The surface-reacted natural or synthetic calcium carbonate can be kept in suspension, optionally further stabilised by a dispersant. Conventional dispersants known to the skilled person can be used. A preferred dispersant is polyacrylic acid.
Alternatively, the aqueous suspension described above can be dried, thereby obtaining the solid (i.e. dry or containing as little water that it is not in a fluid form) surface-reacted natural or synthetic calcium carbonate in the form of granules or a powder.
In a preferred embodiment, the surface-reacted natural or synthetic calcium carbonate has a specific surface area of from 5 m2/g to 200 m2/g, more preferably 20 m2/g to 80 m2/g and even more preferably 30 m2/g to 60 m2/g, measured using nitrogen and the BET method according to ISO 9277.
Furthermore, it is preferred that the surface-reacted natural or synthetic calcium carbonate has a weight median grain diameter of from 0.1 to 50 μm, more preferably from 0.5 to 25 μm, especially from 0.8 to 20 μm, most preferably from 1 to 10 μm, measured according to the sedimentation method. The sedimentation method is an analysis of sedimentation behaviour in a gravimetric field. The measurement is made with a Sedigraph™ 5100 of Micromeritics Instrument Corporation. The method and the instrument are known to the skilled person and are commonly used to determine grain size of fillers and pigments. The measurement is carried out in an aqueous solution of 0.1 wt-% Na4P2O7. The samples were dispersed using a high speed stirrer and supersonicated.
In a preferred embodiment, the surface-reacted natural or synthetic calcium carbonate has a specific surface area within the range of 5 to 200 m2/g and a weight median grain diameter within the range of 0.1 to 50 μm. More preferably, the specific surface area is within the range of 20 to 80 m2/g and the weight median grain diameter is within the range of 0.5 to 25 μm. Even more preferably, the specific surface area is within the range of 30 to 60 m2/g and the weight median grain diameter is within the range of 0.7 to 7 μm.
The surface reacted calcium carrier is capable of associating and transporting an active agent. The association preferably is an adsorption onto the surface of the surface-reacted calcium carbonate particles, be it the outer or the inner surface of the particles or an absorption into the particles, which is possible due to their porosity.
In this respect, it is believed that because of the intra and interpore structure of the surface reacted calcium carbonate, this material is a superior agent to deliver previously ad/absorbed materials over time relative to common materials having similar specific surface areas.
Thus, the ad/absorption characteristics can be controlled by the pore size and/or pore volume and/or surface area for a given agent. Preferably, the surface-reacted natural or synthetic calcium carbonate has an intra- particle porosity within the range of from 5 vol.-% to 50 vol.-%, preferably of from 20 vol.-% to 50 vol.-%, especially of from 30 vol.-% to 50 voL-% calculated from a mercury porosimetry measurement. From the bimodal derivative pore size distribution curve the lowest point between the peaks indicates the diameter where the intra and inter-particle pore volumes can be separated. The pore volume at diameters greater than this diameter is the pore volume associated with the inter- particle pores. The total pore volume minus this inter particle pore volume gives the intra particle pore volume from which the intra particle porosity can be calculated, preferably as a fraction of the solid material volume, as described in Transport in Porous Media (2006) 63: 239-259.
Thus, the intra-particle porosity determined as the pore volume per unit particle volume is within the range of from 20 vol.-% to 99 vol.-%, preferably from 30 vol.- % to 70 vol.-%, more preferably from 40 vol.-% to 60 vol.-%, e.g. 50 vol.-%.
As already mentioned ad/absorption and release of the active agent is essentially controlled by the pore size, which preferably is in a range of from 10 to 100 nm, more preferably in a range of between 20 and 80 nm, especially from 30 to 70 nm, e.g. 50 nm.
Thus, generally, any agent fitting into the intra- and/or inter particle pores of the surface-reacted calcium carbonate carrier is suitable to be transported by the surface- reacted calcium carbonate carriers according to the invention.
Within these ranges any active agent, be it for the transport in or into the human or animal body, in agricultural or any other applications, can be useful in the present invention, e.g. agents selected from the group comprising pharmaceutically, biologically, cosmetically active agents, scented agents or flavoring agents, biocides, pesticides or herbicides, and disinfecting agents.
For example, active agents such as those selected from the group comprising triclosan, anticarcinogens, limonene, peppermint, surfactants like defoamers, or softeners, mineral oils, silicone, wetting agents, wax, paraffin, hydrolytic agents such as hydrolytic binders, anti-dusting oils, and o-phenylphenol and Bronopol can be used.
An especially interesting group of active agents are anticarcinogens, as cancer cells are acidic, and this acidity assists the release of the anticarcinogen at the cancer cells.
If the target environment is the human or animal body, the carriers having an active agent associated therewith according to the invention can be administered directly via the oral way, via inhalation, and via the dermal tissue as mentioned above. They can even be administered via injection to the body, e.g. intravenously or subcutaneously. If sufficient agent is delivered to the target environment, the present invention may even provide an alternate route to providing agents via vaccination.
In a preferred embodiment the surface-reacted calcium carbonate carrier may be combined with one or several further carrier materials, such as for example a chewing gum or tooth paste formulation as regards the oral administration.
Thus, in a preferred embodiment, a tooth paste comprising surface-reacted calcium carbonate as a carrier of, e.g. triclosan, or flavoring agents can be provided.
In the case where the active agent is to be transported into the intestines, the carrier having the active agent associated therewith can be formulated into common galenical formulations such as oil-based capsules such as vitamin capsules, tablets, creams and the like.
In the case of inhalation applications, the carrier may be combined with, e.g. a nasal spray formulation, transporting pharmaceutically active agents, or odorous substances including scented oils such as limonene or peppermint.
Dermal application may be formulated e.g. into a cosmetic formulation which may be applied to the skin or hair. Generally any kind of cosmetic formulations are suitable such as patches, soaps, creams such as skin creams and sunscreens, foundations, hair care products, perfumes, powders such as foot powders or facial powders, lipsticks, deodorants, or bath additives, e.g. in the form of bath bombs or bath tablets, wherein natural oils such as peppermint oil or amaranth oil may be incorporated.
Also, it is possible to use the surface-reacted calcium carbonate suspended in oils such as mineral oil fractions or vegetable oils such as jojoba oil or in alcohols such as ethyl alcohol.
As can be seen from the above the surface-reacted calcium carbonate carrier is useful to transport various agents associated therewith.
There are, however, some limitations, which therefore are excluded from the subject- matter of the present invention. Thus, agents reacting with the surface-reacted calcium carbonate such as acidic agents sometimes are not suitable to be transported with the surface-reacted calcium carbonate. On the other hand, even acidic agents may be advantageously used, e.g., if the calcium salt of the acidic agent is required or beneficial. A certain level of acidity can also enhance adsorption to the surface of the carrier. The delivery mechanism, following ab/adsorption of the agent onto and/or into the surface-reacted calcium carbonate is essentially based on one or several of the following mechanisms:
1. by diffusion out of tablet or a similar macroscopic body formed out of surface-reacted calcium carbonate particles (slow, continuous release)
2. by diffusion out of discrete particles of surface-reacted calcium carbonate particles, be it in the form of a powder or a suspension (medium slow, continuous releas e)
3. by destruction of the tablet or a similar macroscopic body formed out of surface-reacted calcium carbonate particles, for example by application of a mechanical force on the tablet (chewing)(release first slow, then medium slow) 4. A special case is given by the situation when the surface-reacted calcium tablet is loaded with a hydrophobic agent such as an oil and the tablet is then immersed in a polar fluid such as water. There is a rapid disintegration observed due to the invading pressure of the water. 5. By destruction of the surface-reacted calcium particle structure itself Destruction could take place (fast, localized release as soon as particle structure decays);
The association, i.e. ad/absorption of the agent onto and/or into the surface-reacted calcium carbonate carrier is generally effected by contacting the surface reacted calcium carbonate with a solution or suspension of the active agent in a suitable medium, which is preferably water, but can generally be any medium. However, if the medium is acidic, it needs to be weaker than the acid that formed the reacted surface salt and in dilute form. Then it can be exposed to a low pH for a limited time at least. For this purpose, the surface-reacted calcium carbonate may be in the form of a tablet or powder, which after the association is completed is separated from the excess liquid, solution or suspension, e.g. by filtration, and optionally dried.
The resulting loaded tablet or powder is applied directly or combined with a second carrier as described above, such as a cream, a tablet, capsule or any other galenical form as described above according to methods well-known in the art.
With respect to the drying of the surface reacted calcium carbonate, it is preferred to apply a well controlled drying method, such as gentle spray drying or oven-drying.
The following figures, examples and tests will illustrate the present invention, but are not intended to limit the invention in anyway.
Description of the figures:
Figure 1 shows a SEM image of surface-reacted calcium carbonate useful in the present invention
Figure 2 shows an apparatus designed and suitable for making surface-reacted calcium carbonate tablets from wet suspensions.
Figure 3 shows a schematic cross-section of a die used for compacting powders.
Figure 4 shows a graph illustrating the release characteristics of a carrier according to the invention and a comparative sample. Figure 5 shows a graph illustrating the sustained release effect of surface-treated calcium carbonate compared with conventional calcium carbonate
Examples:
Example 1: Release characteristics
For comparing the release characteristics of the carrier according to the invention a tablet of surface reacted calcium carbonate was formed, as well as of a silica reference product featuring a similar high surface area as the surface-reacted calcium carbonate.
Preparation of surface-reacted calcium carbonate
The surface-reacted calcium carbonate was prepared in a 100 litre E SCO-reactor.
8000 g of dry natural calcium carbonate having a d50 of 0.7 μm (Sedigraph) (64 wt- % < 1 μm) was filled into the vessel. Then water was added until a solids content of 10 wt.-% was obtained. The resulting slurry was heated to 70 0C5 then 3733 g of phosphoric acid ( = 35 wt.-% dry/dry) was added during 90 minutes at a solids content of 75 wt.-%, under stirring with an anchor stirrer at 50 rpm and a disc stirrer at 2000 rpm. 30 minutes after the completion of the addition the temperature was decreased and the slurry upconcentrated in a filter press. The surface-reacted calcium carbonate used in the following example had a number mean particle size dso (Sedigraph) of 3 μm a rose-like surface structure as can be taken from figure 1 - a pH of7.5 to 9.5
- a specific surface area as measured by BET: 60 m2/g
Preparation of surface-reacted calcium carbonate tablets
The tablet was made from a suspension of surface-reacted calcium carbonate having a solids content of 30 wt-% ± 5 wt.-%. The tablets were formed by applying a constant pressure to the suspension for several minutes, typically 1-10 min, such that water is released by filtration through a fine 0.025 μm filter membrane resulting in a compacted tablet of the surface-reacted calcium carbonate. The apparatus used is illustrated in figure 2. It is further described in: Ridgway, C. J., Gane, P. A. C. and Schoelkopf, J., "Modified Calcium Carbonate Coatings with Rapid Absorption and Extensive Liquid Uptake Capacity", Colloids and Surfaces A, 236(1-3), 2004, p. 91- 102.
The tablets were removed from the apparatus and dried in an oven at 8O0C for 24 hours.
Preparation of reference tablets
The silicates used as a reference were products available under the tradename GASIL® HP39 and PlOl available from INEOS Silicas and had the following characteristics:
Figure imgf000017_0001
The silicate powders were formed into tablets in the form of blocks by a dry compaction method as follows:
For the preparation of the pigment blocks a cylindrical hardened steel die attached to a base plate with a single acting upper piston was used which is suitable for a wide range of particle sizes, chemistries and morphologies. The die is divisible into two parts to aid removal of the compacted pigment sample and the walls of the die are protected with a strip of plastic film to prevent sticking of the powder to the wall and to reduce edge friction (Fig. 3).
Further details of the method for producing such kind of tablet blocks can be taken e.g. from Pennanen M., "Methods for producing and testing tablets of dry pigments and coating colors", Research report, Abo Akademi, Turku and OMYA, Oftringen, 1996; Ridgway C. J., Ridgway K., Matthews G. P., "Modelling of the void space of tablets compacted over a range of pressures", J. Pharm. Pharmacol. 49, (1997), p. 377; and: Gane, P. A. C, Schoelkopf, J., Spielmann, D. C, Matthews, G. P., Ridgway, C. J., "Fluid Transport into Porous Coating Structures: Some Novel Findings", Tappi Journal, 83(5), 2000, p. 77-78.
Association of active agent
The surface-reacted calcium carbonate tablets, which were previously ground to a cubic shape, as well as the silicate blocks were placed in dishes. Limonene (pure or in alcohol/water) was added to the dishes such that the top surfaces of the tablets remained in contact with air (allowing any air in the tablets to escape as limonene is absorbed).
Wetting continued for an additional 12 hours following the visual observation that the surfaces of the cubes and blocks are wetted by the limonene.
The tablets were removed from the dish and allowed to stand in an open environment under standard temperature and pressure conditions until limonene could not be detected by smelling any more (for up to 350 hours). At this point, the tablets were placed in a closed jar and heated in order to analyze the weight of remaining limonene.
In all cases, surface reacted calcium carbonate provided for a slower release of limonene than silica (Fig. 4; The percentages given refer to wt-% limonene in ethyl alcohol; W449 refers to limonene loaded surface reacted calcium carbonate according to the invention, D 304 refers to limonene loaded HP 39 silicate; D 297 refers to limonene loaded PlOl silicate as described above).
The quantification was carried out by gas chromatography in a HS TurboMatrix 40
Trap Perkin Elmer using the following parameters:
Temp. Mode: Oven 9O0C, Needle 100°C, Transfer 1100C, Trap Low 400C, Trap
High 2800C
Timing: Thermo 20.0 min, Delay: 0.8 min, Pressurize 1.0 min, Dry Purge 5.0 min, Desorb. 0.1 min, Trap Hold 5.0 min
Column: 101 kPa, Vial: 101 kPa, Desorb: 101 kPa GC Method AutoSystem XL
Perkin Elmer
Column: Optima 5 MS 1.0 μm, 50m * 0.32 mm, Macherey-Nagel Injector 1300C,
Split on Temp.: 13O0C 1.0 min, 10°C/min to 22O0C 0.0 min Pressure: 70 kPa MS Turbo Mass Perkin Elmer Solvent Delay 4.5 min Full Scan 25 to 300 (EI+)
Calibration: 0.0200 g Limonene / 100 ml EtOH 0.0517 g Limonene / 50 ml EtOH 0.1050 g Limonene / 50 ml EtOH 0.2394 g Limonene/ 50 ml EtOH 0.7597 g Limonene / 50 ml EtOH
0.5 μl injected in a HS vial (0.100 μg / 0.517 μg / 1.050 μg / 2.394 μg / 7.597 μg
Limonene)
Korrelation r2: 0.9994
Example 2: Transport and release of oily substances in an aqueous environment
For illustrating the properties of the carrier according to the present invention with respect to the transport and release of oily substances in an aqueous environment, bath bombs and bath tablets were produced with surface-reacted calcium carbonate saturated with scents (natural oils) such as amaranth as well as peppermint oil. The bath bombs or bath tablets were dropped into water at a temperature of 37 °C in order to extract and evaluate the released oil.
1. Bath bombs a) Material
- Surface-reacted calcium carbonate: prepared as described under Example 1 above
- Natural oil: Amaranth oil
- Additives: Citric acid
Sodium bicarbonate Hamamaelis water witch hazel Colour Vitasin Patentblue (Clariant) Food coloring red Food coloring yellow
- Solvent: n-Heptane
b) Compositions
Figure imgf000020_0001
c ) Preparation of the bath bombs
Citric acid and sodium bicarbonate were provided and well blended manually in a mortar. The colour solutions were added and well mixed. Subsequently, the given amounts of surface-reacted calcium carbonate and amaranth oil were added, either by adding the surface-reacted calcium carbonate saturated with the amaranth oil and manually well mixed (sample 1 and 3), or by adding the components separately (sample 2). Onto these batches witch hazel was sprayed (with a squirt bottle) while stirring manually. As soon as the batch sticks together upon squishing, potions of the bulk are put into a conventional aluminium form.
Any one of the resulting bombs was dried over night at room temperature. Then, each bomb was put into a 2000 ml beaker filled with 1000 ml tap water at approx. 37
°c.
After the resulting suspension (amaranth) had cooled down to less than 30 ° C (in approx. 30 to 40 min.), the whole contents were extracted with heptane in a separation funnel.
The water phase (pH 6,6 ± 0.2) was discarded; the oil/solvent phase was filled into a 50 ml brown glass bottle and analyzed by determining the weight after evaporation of the solvent. The appearance of the solvent phases is turbid, milky white for the amaranth sample.
d) Results and discussion
Figure imgf000021_0001
It can be taken from the above table that it is more favourable to saturate the calcium carbonate with the oil instead of just mixing it, wherein the recovery rate in samples Ia and b are very high confirming the good performance of the present invention with respect to the release of oily substances in an aqueous environment. 2. Bath Tablets
a) Material
- Surface-reacted calcium carbonate: prepared as described under Example 1 above
- Natural oils: Amaranth oil
- Additives: Citric acid
Sodium bicarbonate Hamamaelis aqua witch hazel
- Solvent: n-Heptane
b) Preparation of the bath tablets
Sample 4:
55 wt-% of a citric acid / sodium bicarbonate mixture (in a weight ratio of 1 : 2) were manually blended with 10 wt-% amaranth oil in a mortar. 35 wt-% of surface-reacted calcium carbonate were added in order to obtain a powdery batch.
Sample 5:
35 wt-% of surface-reacted calcium carbonate were manually mixed with 10 wt-% amaranth oil in a mortar. The mixture was then added to 55 wt-% of a citric acid / sodium bicarbonate mixture (in a weight ratio of 1 : 2) and manually mixed in order to obtain a powdery batch. Sampleό:
34.5 wt-% of surface-reacted calcium carbonate were manually mixed with 10 wt-% amaranth oil in a mortar. The mixture was then added to 54.5 wt-% of a citric acid / sodium bicarbonate mixture (in a weight ratio of 1 : 2) and manually mixed in order to obtain a powdery batch. While squishing manually, 2 wt-% of Hanmamelis water witch hazel was sprayed onto the batch in order to get a sticky powder.
From each of these samples tablet structures were formed by using a cylindrical hardened steel die attached to a base plate with a single acting upper piston. The die is divisible into two parts to aid removal of the compacted powder sample and the walls of the die are protected with a strip of plastic film to prevent sticking of the powder to the wall and to reduce edge friction. Additionally, the powders were covered with a cellulose membrane at the bottom as well as on top before being compacted in a hydraulic press for 1 minute at a predetermined force of 15 kN (an effective pressure of 35 bar). The tablets were formed of 1.5 to 1.8 cm in height and a diameter of 4.8 cm. All tablets were well compacted.
The height of the powder in the instrument was approximately 4.5 to 5 cm (the maximum height of the cylindrical steel is 8 cm).
c) Results and discussion
Subsequently, 1O g of each tablet were dissolved in tap water at 37 - 38 °C. The dissolution took about 6 minutes for samples 4 and 5 and more than 6 minutes for sample 6. Example 3: Transport and release of oily substances in an oily environment
For illustrating the properties of the carrier according to the present invention with respect to the transport and release of oily substances in an oily environment, as it is often present in cosmetic formulations, a formulation of surface-reacted calcium carbonate was compared with a formulation of non surface-reacted calcium carbonate.
a) Material
- Surface-reacted calcium carbonate: prepared as described under Example 1 above
- Commercially available non surface-reacted calcium carbonate (Omyacarb 2 of OMYA AG)
- Commercially available methylbutyl isovalerat - Hexadecane
- GC-MS: - Before GC-MS analysis, the samples were 21.25 x diluted in hexadecane
(80μl sample and 1620 μl solvent) - GC Method AutoSystem XL Perkin Elmer Column: Optima 5 MS 1.0 μm, 50m * 0.32 mm, Macherey-Nagel
Injector 3000C5 Split on Temp.: 22O0C 8.0 min Pressure: 70 kPa
- MS Turbo Mass Perkin Elmer
Solvent Delay 3.74 min SIR Scan, Mass 43, 70, 85 3.75 to 8.0 min (EI+) b) Preparation of the formulations
2g of each of the calcium carbonate samples was manually mixed with a spatula in a dish with O.Oόg of methylbutyl isovalerat.
100 ml hexadecane were placed into a dish on an electric stirring base. A magnet was placed in the dish and allowed to turn at a minimal rotation speed.
The pigment / methylbutyl isovalerat mixture was placed in the dish with the hexadecane to one side away from the stirrer. After a certain time period, a sample of the fluid phase was removed for analysis.
This process was repeated for increasing lengths of time, each time using a fresh calcium carbonate / methylbutyl isovalerat mixture.
c) Results and discussion
The following table also showing the mixture weights as well as the time periods of the experiments, as well as Figure 5 clearly illustrate the sustained release effect of surface-treated calcium carbonate compared with conventional calcium carbonate.
Figure imgf000026_0001
Example 4: Further formulations comprising the carrier of the invention
1. Tooth pastes
a) Preparation of surface-reacted calcium carbonate
The surface-reacted calcium carbonate was prepared in a 5 m3 reactor.
414kg of dry natural calcium carbonate (undispersed marble) having a dso of 3 μm (Sedigraph) was filled into the vessel. Then water was added until a solids content of 15 wt.-% was obtained. The resulting slurry was heated to 70 0C, then phosphoric acid (in the form of a 30% by mass solution) was added in an amount corresponding to 30 wt.-% dry/dry during 11 minutes, under stirring at 200 rpm. 5 minutes after the completion of the addition the temperature was decreased and the slurry filtered on a drum filter and then dried using a flash dryer.
The surface-reacted calcium carbonate used in the following example had
- a number mean particle size d5o (Sedigraph) of 4.5 μm
- a rose-like surface structure
- a pH of 7.5 to 9.5
- a specific surface area as measured by BET: 40 m2/g
b) Material
Figure imgf000027_0001
c) Preparation of a toothpaste formulation
Sorbitol, sodium monofluorophosphate, potassium acesulfam and water were thoroughly mixed together. To this mixture, a non surface reacted calcium carbonate powder / titanium dioxide powder blend was added and wetted therewith. Then, a mixture of surface-reacted calcium carbonate as described above and spearmint aroma, which was dropwise added to the surface reacted calcium carbonate while manually stirring, and, subsequently, cellulose gum were added while stirring in order to obtain a homogenous paste. The paste is further stirred slowly and cooled down to room temperature. Then, sodium lauryl sulphate in water / cocamidopropyl betaine is slowly added while stirring, under vacuum if required.
2. Skin Care formulation
This example describes the loading of an oil in water emulsion into surface-reacted calcium carbonate acting as a carrier in a skin care formulation.
If the oil itself is loaded into the surface-reacted calcium carbonate, it would be displaced by water as soon as the loaded surface-reacted calcium carbonate is introduced into an aqueous formulation. Subsequently the oil would be visible as floating macroscopic droplets.
a ) Preparation of surface-reacted calcium carbonate
The surface-reacted calcium carbonate was prepared in a 10 m reactor.
1700 kg of dry natural calcium carbonate having a d50 of 1.6 μm (Sedigraph) was filled into the vessel. Then, water was added until a solids content of 27 wt.-% was obtained. The resulting slurry was heated to 550C, then phosphoric acid (in the form of a 35% by mass solution) was added in an amount corresponding to 13 wt.-% dry/dry during 20 minutes, under stirring at 100 rpm. 10 minutes after the completion of the addition the temperature was decreased and the slurry filtered on Sweco filter and then dried using a jet dryer.
The surface-reacted calcium carbonate used in the following example had
- a number mean particle size d5o (Sedigraph) of 2.2 μm a rose-like surface structure
- a pH of 7.5 to 9.5 - a specific surface area as measured by BET: > 25 m /g
b) Preparation of a skin care formulation
First, an emulsion was prepared. This operation was carried out by using a rotor- stator dϊssolver from Kinematika, Polytron PT 300 at 10000 min"1. For the preparation of the emulsion, 94.031 g of demineralised water was charged with 1.028 g of PEG-40 hydrogenated castor oil and homogenised until the emulsifier is well dissolved. Subsequently, 5.001 g of amaranth oil was added dropwise and dispersed well until a homogeneous milky emulsion was formed.
In a next step, the surface-reacted calcium carbonate was loaded with the resulting emulsion. For this step 15.004 g of surface-reacted calcium carbonate was weighed into a ceramic mortar (0 180 mm) and 20.209 g of the emulsion was added dropwise under mixing with pestle into the surface-reacted calcium carbonate until a white glossy creme was formed.
Then, the loaded surface-reacted calcium carbonate was blended with a gel formulation having the following composition:
Figure imgf000030_0001
The gel formulation was prepared by mixing 1,2-propanediol, butylene glycol and water, subsequent interspersing under stirring ammonium acryloyldimethyltaurate / VP Copolymer and allowing swelling resulting in a gel. Then, Lauryl PEG/PPG- 18/18 Methicone, PEG- 12 Dimethicone, Shea Blend Emulsion, Silicone Elastomer Suspension, Liposome, non-ionic emulsion and Phenochem were mixed under stirring and added to the gel. To this emulsion gel the mixture of 25 % menthyl lactate solution in ethanol and 10 % sodium hydroxide solution was added, and the resulting gel was quickly and intensively homogenized and stirred for another 15 minutes. For obtaining the skin care formulation, 20 g of the loaded surface-reacted calcium carbonate was blended manually with 100 g of the gel formulation until a homogenous white glossy creme was formed.
The resulting creme had - a pH ofό.94 - a Brookfield viscosity of 23480 mPa-s (Brookfield DV-II (RT; RV 5, 30s/10rpm))

Claims

C l a i m s
1. Carrier for the controlled release of active agents, comprising: - surface reacted natural or synthetic calcium carbonate, - one or more active agents, wherein said one or more active agent is associated with said surface-reacted calcium carbonate, and wherein said surface-reacted natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source.
2. The carrier according to claim 1 , characterized in that the surface-reacted natural or synthetic calcium carbonate is in the form of a solid or in the form of an aqueous suspension comprising the surface- reacted calcium carbonate and having a pH greater than 6.0 measured at 20 0C.
3. The carrier according to any one of claims 1 to 2, characterized in that the natural calcium carbonate is selected from the group comprising marble, calcite, chalk and dolomite, limestone and mixtures thereof.
4. The carrier according to any one of claims 1 to 2, characterized in that the synthetic calcium carbonate is precipitated calcium carbonate comprising aragonitic, vateritic or calcitic mineralogical crystal forms or mixtures thereof.
5. The carrier according to any one of the preceding claims, characterized in that the acids are selected from the group comprising hydrochloric acid, sulphuric acid, sulphurous acid, hydrosulphate, phosphoric acid, oxalic acid and mixtures thereof.
6. The carrier according to any one of the preceding claims, characterized in that the surface-reacted natural or synthetic calcium carbonate has a specific surface area of from 5 m2/g to 200 m2/g, preferably 20 m2/g to 80 m2/g and more preferably 30 m /g to 60 m /g, measured using nitrogen and the BET method according to ISO 9277.
7. The carrier according to any one of the preceding claims, characterized in that the surface-reacted natural or synthetic calcium carbonate has a weight median grain diameter dso of from 0.1 to 50 μm, preferably from 0.5 to 25 μm, more preferably 0.8 to 20 μm, particularly 1 to 10 μm measured according to the sedimentation method.
8. The carrier according to any one of the preceding claims, characterized in that the surface-reacted natural or synthetic calcium carbonate has an intra-particle porosity determined as the pore volume per unit particle volume within the range of from 20 vol.-% to 99 vol.-%, preferably from 30 vol.-% to 70 vol.-%5 more preferably from 40 vol.-% to 60 vol.-%, e.g. 50 vol.-%, calculated from a mercury porosimetry measurement.
9. The carrier according to any one of the preceding claims, characterized in that the one or more active agents are adsorbed onto and/or absorbed into the surface-reacted calcium carbonate.
10. The carrier according to any one of the preceding claims, characterized in that the one or more active agents are selected from the group comprising pharmaceutically, biologically active agents, scented agents or flavoring agents, biocides, pesticides or herbicides, and disinfecting agents.
11. The carrier according to any one of claims 1 to 9, characterized in that the active agents are selected from the group comprising triclosan, anticarcinogens, limonene, peppermint, surfactants like defoamers, or softeners, mineral oils, silicon, wetting agents, wax, paraffin, hydrolytic agents such as hydrolytic binders, anti-dusting oils, and o-phenylphenol and Bronopol.
12. The carrier according to any one of the preceding claims, characterized in that the surface-reacted calcium carbonate carrier may be combined with one or several further carrier materials.
13. The carrier according to claim 12, characterized in that the one or several further carrier materials are selected from the group comprising chewing gums, tooth paste, capsules, tablets, creams, spray formulations, patches soaps, creams such as skin creams and sunscreens, foundations, hair care products, perfumes, powders such as foot powders or facial powders, lipsticks, deodorants, or bath additives, oils such as a mineral oil fractions or vegetable oils such as jojoba oil or in alcohols such as ethyl alcohol.
14. The carrier according to any one of the preceding claims, characterized in that the surface-reacted calcium carbonate may be in the form of a tablet or powder.
15. The carrier according to any one of the preceding claims for the use in pharmaceutical, biological, cosmetic, or agricultural applications.
16. Method for preparing a loaded carrier according to any one of the preceding claims, characterized by the steps of - providing the surface-reacted calcium carbonate in the form of a tablet or powder
- providing the active agent in the form of a solution or suspension in a suitable medium;
- contacting the surface-reacted calcium carbonate with the active agent until the association is completed, - separating the loaded carrier from the excess liquid, solution or suspension.
17. Use of a carrier according to any one of claims 1 to 15 for transporting an active agent to a target environment.
PCT/EP2009/062633 2008-09-30 2009-09-29 New controlled release active agent carrier WO2010037753A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US12/998,060 US9744107B2 (en) 2008-09-30 2009-09-29 Controlled release active agent carrier
EP09817294A EP2331073A1 (en) 2008-09-30 2009-09-29 New controlled release active agent carrier
JP2011529537A JP2012504577A (en) 2008-09-30 2009-09-29 Novel controlled release active agent carrier
RU2011117358/15A RU2502506C2 (en) 2008-09-30 2009-09-29 New controlled-release active agent carrier
AU2009299882A AU2009299882B2 (en) 2008-09-30 2009-09-29 New controlled release active agent carrier
CA2737395A CA2737395A1 (en) 2008-09-30 2009-09-29 New controlled release active agent carrier
CN200980138343.1A CN102170867B (en) 2008-09-30 2009-09-29 New controlled release active agent carrier
US14/970,746 US9757314B2 (en) 2008-09-30 2015-12-16 Controlled release active agent carrier
US15/646,657 US10045919B2 (en) 2008-09-30 2017-07-11 Controlled release active agent carrier
US15/671,620 US10137066B2 (en) 2008-09-30 2017-08-08 Controlled release active agent carrier

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08165543A EP2168572A1 (en) 2008-09-30 2008-09-30 New controlled release active agent carrier
EP08165543.3 2008-09-30
US19632208P 2008-10-15 2008-10-15
US61/196,322 2008-10-15

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US12/998,060 A-371-Of-International US9744107B2 (en) 2008-09-30 2009-09-29 Controlled release active agent carrier
US14/970,746 Continuation US9757314B2 (en) 2008-09-30 2015-12-16 Controlled release active agent carrier
US15/646,657 Division US10045919B2 (en) 2008-09-30 2017-07-11 Controlled release active agent carrier

Publications (1)

Publication Number Publication Date
WO2010037753A1 true WO2010037753A1 (en) 2010-04-08

Family

ID=40342987

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/062633 WO2010037753A1 (en) 2008-09-30 2009-09-29 New controlled release active agent carrier

Country Status (11)

Country Link
US (4) US9744107B2 (en)
EP (2) EP2168572A1 (en)
JP (1) JP2012504577A (en)
KR (1) KR101638643B1 (en)
CN (1) CN102170867B (en)
AR (1) AR073519A1 (en)
CA (1) CA2737395A1 (en)
RU (1) RU2502506C2 (en)
TW (1) TWI453040B (en)
UY (1) UY32151A (en)
WO (1) WO2010037753A1 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010238945B2 (en) * 2009-04-24 2013-10-24 Omya International Ag Particulate material for controlled release of active ingredients
EP2706974A2 (en) * 2011-05-12 2014-03-19 Thorel, Jean-Noël Topical cosmetic composition containing an improved pro-penetrating system
EP2719373A1 (en) 2012-10-12 2014-04-16 Omya International AG Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
US20150231078A1 (en) * 2012-10-12 2015-08-20 Omya International Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
EP2921173A1 (en) 2014-03-21 2015-09-23 Omya International AG Surface-reacted calcium carbonate for desensitizing teeth
EP2926797A1 (en) 2014-03-31 2015-10-07 Omya International AG Surface-reacted calcium carbonate for remineralisation and whitening of teeth
EP2949708A1 (en) 2014-05-30 2015-12-02 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP2957603A1 (en) 2014-06-20 2015-12-23 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP2997833A1 (en) 2014-09-22 2016-03-23 Omya International AG Surface-reacted calcium carbonate for use as anti-caking agent
EP3045042A1 (en) 2015-01-15 2016-07-20 Omya International AG Use of surface-reacted calcium carbonate as carrier for agrochemical compounds
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3070057A1 (en) 2015-03-16 2016-09-21 Omya International AG Process for the purification of water
US20160271025A1 (en) * 2013-12-13 2016-09-22 Omya International Ag Abrasive cleaning composition
EP3175835A1 (en) 2015-12-04 2017-06-07 Omya International AG Oral care composition for remineralisation and whitening of teeth
EP3176222A1 (en) 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3183965A1 (en) 2015-12-23 2017-06-28 Omya International AG Composition for aquatic pest control
EP3257501A1 (en) 2016-06-14 2017-12-20 Tillotts Pharma AG Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating
EP3311665A1 (en) 2016-10-21 2018-04-25 Omya International AG Use of surface-reacted calcium carbonate for preparing supersaturated aqueous systems
US10351710B2 (en) 2014-05-30 2019-07-16 Omya International Ag Method for the production of granules comprising surface-reacted calcium carbonate
US10391061B2 (en) 2013-09-20 2019-08-27 Tillotts Pharma Ag Delayed release pharmaceutical formulation and methods of making and using same
EP3599016A1 (en) 2018-07-24 2020-01-29 Omya International AG Heavy metal removal using minerals being functionalized with thiols
EP3599224A1 (en) 2018-07-24 2020-01-29 Omya International AG Particulate mineral materials functionalized with reducing agents for lowering the amount of heavy metal contaminants from an aqueous medium
EP3599223A1 (en) 2018-07-24 2020-01-29 Omya International AG Heavy metal removal using minerals being functionalized with adsorption enhancers
US10821222B2 (en) 2014-07-21 2020-11-03 Medtronic Minimed, Inc. Smart connection interface
WO2021219529A1 (en) 2020-04-28 2021-11-04 Omya International Ag Method for the production of free-flowing granules
WO2021219458A1 (en) 2020-04-28 2021-11-04 Omya International Ag Granules comprising surface-reacted calcium carbonate as excipient
WO2022144403A1 (en) 2021-01-04 2022-07-07 Omya International Ag Delivery system for plant protection
US11400050B2 (en) 2016-06-21 2022-08-02 Omya International Ag Method for the production of a dosage form
US11617828B2 (en) 2019-07-17 2023-04-04 Medtronic Minimed, Inc. Reservoir connection interface with detectable signature
US12115258B2 (en) 2018-09-17 2024-10-15 Omya International Ag High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
CN105822337A (en) * 2008-12-08 2016-08-03 Itw澳大利亚控股有限公司 Stone dusting
EP2415829A1 (en) * 2010-07-30 2012-02-08 Schaefer Kalk GmbH & Co. KG Dry liquid
TWI625129B (en) * 2011-11-10 2018-06-01 歐米亞國際公司 New coated controlled release active agent carriers
EP3075376A1 (en) * 2011-11-10 2016-10-05 Omya International AG New coated controlled release active agent carriers
PL2626388T3 (en) 2012-02-09 2017-08-31 Omya International Ag A composition and method for controlling the wettability of surfaces
KR101989066B1 (en) * 2012-11-15 2019-06-14 (주)아모레퍼시픽 Composition for improving scalp or hair condition
PT2957301T (en) * 2014-06-20 2017-07-06 Omya Int Ag Method for the control of odour
EP3034070A1 (en) * 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
JP6802168B2 (en) * 2015-01-14 2020-12-16 アイメリーズ ユーエスエー,インコーポレーテッド Method Process for Converting Natural Calcium Carbonate to Precipitated Calcium Carbonate
KR101705775B1 (en) 2015-01-30 2017-02-13 전북대학교 산학협력단 Insecticidal composition for controlling stored product insects
RU2633928C1 (en) * 2016-08-24 2017-10-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" Method of transdermal delivery of biologically active substances
EP3360601A1 (en) * 2017-02-09 2018-08-15 Omya International AG Functionalized calcium carbonate for sun protection boosting
EP3400810A1 (en) * 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
EP3517176A1 (en) * 2018-01-26 2019-07-31 Omya International AG Surface-reacted calcium carbonate for the use as skin appearance modifier
EP3517178A1 (en) * 2018-01-26 2019-07-31 Omya International AG Surface-reacted calcium carbonate for modifying the biomechanical properties of the skin
EP3733785A1 (en) * 2019-05-03 2020-11-04 Omya International AG Surface-reacted magnesium carbonate as carrier material for the release of one or more active agent(s) in a home care formulation
CN112618420A (en) * 2021-01-12 2021-04-09 上海应用技术大学 Jojoba oil-loaded microcapsule and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040020410A1 (en) * 1998-12-24 2004-02-05 Omya Ag Filler or pigment or processed mineral for paper, in particular a pigment containing natural CaCO3, its manufacturing process, preparations containing it and their applications
WO2008113838A1 (en) * 2007-03-21 2008-09-25 Omya Development Ag Process for the removal of endocrine disrupting compounds
WO2008113840A1 (en) * 2007-03-21 2008-09-25 Omya Development Ag Surface treated calcium carbonate and its use in waste water treatment

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3357790A (en) * 1963-03-18 1967-12-12 Monsanto Co Calcining method for conversion of alkaline earth orthophosphates to the pyrophosphate form
JPS5390199A (en) * 1977-01-20 1978-08-08 Shiraishi Kogyo Kaisha Ltd Method of modifying calcium carbonate
US4379168B1 (en) * 1980-03-14 1990-01-23 Pesticides containing d-limonene
JPS5964527A (en) 1982-09-29 1984-04-12 Shiraishi Chuo Kenkyusho:Kk Amorphous calcium carbonate, its preparation and material for releasing substance adsorbed to it at proper rate
US4678662A (en) * 1985-10-09 1987-07-07 Monsanto Company Pyrophosphate coating process for calcium carbonate dental abrasives
JP3634404B2 (en) * 1993-12-14 2005-03-30 丸尾カルシウム株式会社 Porous calcium carbonate compound and method for producing the same
JP3775569B2 (en) * 2000-11-20 2006-05-17 有限会社ニューライム研究社 Synthetic calcium carbonate based spherical porous granule and method for producing the same
US7294187B2 (en) * 2001-01-24 2007-11-13 Ada Foundation Rapid-hardening calcium phosphate cement compositions
JP3884635B2 (en) 2001-09-03 2007-02-21 矢橋工業株式会社 Calcium carbonate porous particles and production method thereof
WO2004076352A1 (en) * 2003-02-27 2004-09-10 Okutama Kogyo Co., Ltd. Spherical calcium carbonate and method for production thereof
FR2852600B1 (en) 2003-03-18 2005-06-10 NEW MINERAL PIGMENT CONTAINING CALCIUM CARBONATE, AQUEOUS SUSPENSION CONTAINING SAME AND USES THEREOF
US8226931B2 (en) * 2003-11-12 2012-07-24 Symrise Ag Mixture with wintergreen odor and flavor
US8597617B2 (en) * 2004-12-21 2013-12-03 Colgate-Palmolive Company Coated natural calcium carbonate oral care toothpowder composition
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
JP5144910B2 (en) 2006-09-08 2013-02-13 ライオン株式会社 Medicinal component composite fine particle aqueous dispersion, method for producing the same, and oral composition
SI1975310T1 (en) * 2007-03-21 2012-06-29 Omya Development Ag Process for the control of pitch
DE602007009124D1 (en) 2007-12-12 2010-10-21 Omya Development Ag Process for the preparation of surface-reactive precipitated calcium carbonate
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
JP5732043B2 (en) 2009-04-24 2015-06-10 オムヤ インターナショナル アーゲー Particulate material for controlled release of active ingredients
JP5964527B1 (en) 2016-02-19 2016-08-03 光洋サーモシステム株式会社 Ring member manufacturing method and heat treatment ring holder

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040020410A1 (en) * 1998-12-24 2004-02-05 Omya Ag Filler or pigment or processed mineral for paper, in particular a pigment containing natural CaCO3, its manufacturing process, preparations containing it and their applications
WO2008113838A1 (en) * 2007-03-21 2008-09-25 Omya Development Ag Process for the removal of endocrine disrupting compounds
WO2008113840A1 (en) * 2007-03-21 2008-09-25 Omya Development Ag Surface treated calcium carbonate and its use in waste water treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2331073A1 *

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010238945B2 (en) * 2009-04-24 2013-10-24 Omya International Ag Particulate material for controlled release of active ingredients
EP2706974A2 (en) * 2011-05-12 2014-03-19 Thorel, Jean-Noël Topical cosmetic composition containing an improved pro-penetrating system
US20160256393A1 (en) * 2012-10-12 2016-09-08 Omya International Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
EP2719373A1 (en) 2012-10-12 2014-04-16 Omya International AG Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
WO2014057038A1 (en) 2012-10-12 2014-04-17 Omya International Ag Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
US20150231078A1 (en) * 2012-10-12 2015-08-20 Omya International Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
KR101740835B1 (en) * 2012-10-12 2017-05-26 옴야 인터내셔널 아게 Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
US9987230B2 (en) 2012-10-12 2018-06-05 Omya International Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
US9993428B2 (en) 2012-10-12 2018-06-12 Omya International Ag Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
AU2013328639B2 (en) * 2012-10-12 2016-09-15 Omya International Ag Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
US10391061B2 (en) 2013-09-20 2019-08-27 Tillotts Pharma Ag Delayed release pharmaceutical formulation and methods of making and using same
EP2883573B2 (en) 2013-12-13 2020-10-28 Omya International AG Abrasive cleaning composition
US20160271025A1 (en) * 2013-12-13 2016-09-22 Omya International Ag Abrasive cleaning composition
US10780031B2 (en) 2013-12-13 2020-09-22 Omya International Ag Abrasive cleaning composition
EP2883573B1 (en) 2013-12-13 2017-10-25 Omya International AG Abrasive cleaning composition
US10463693B2 (en) 2014-03-21 2019-11-05 Omya International Ag Surface-reacted calcium carbonate for desensitizing teeth
EP2921173A1 (en) 2014-03-21 2015-09-23 Omya International AG Surface-reacted calcium carbonate for desensitizing teeth
WO2015140308A1 (en) 2014-03-21 2015-09-24 Omya International Ag Surface-reacted calcium carbonate for desensitizing teeth
AU2015239968B2 (en) * 2014-03-31 2017-05-25 Omya International Ag Surface-reacted calcium carbonate for remineralisation and whitening of teeth
WO2015150011A1 (en) 2014-03-31 2015-10-08 Omya International Ag Surface-reacted calcium carbonate for remineralisation and whitening of teeth
EP2926797A1 (en) 2014-03-31 2015-10-07 Omya International AG Surface-reacted calcium carbonate for remineralisation and whitening of teeth
EP2926797B1 (en) * 2014-03-31 2017-09-06 Omya International AG Surface-reacted calcium carbonate for remineralisation and whitening of teeth
US10351710B2 (en) 2014-05-30 2019-07-16 Omya International Ag Method for the production of granules comprising surface-reacted calcium carbonate
EP2949708A1 (en) 2014-05-30 2015-12-02 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP2957603A1 (en) 2014-06-20 2015-12-23 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
US11083838B2 (en) 2014-07-21 2021-08-10 Medtronic Minimed, Inc. Smart connection interface
US10821222B2 (en) 2014-07-21 2020-11-03 Medtronic Minimed, Inc. Smart connection interface
US11185627B2 (en) 2014-07-21 2021-11-30 Medtronic Minimed, Inc. Smart connection interface
EP2997833A1 (en) 2014-09-22 2016-03-23 Omya International AG Surface-reacted calcium carbonate for use as anti-caking agent
EP2997833B1 (en) * 2014-09-22 2018-01-31 Omya International AG Surface-reacted calcium carbonate for use as anti-caking agent
RU2679841C1 (en) * 2015-01-15 2019-02-13 Омиа Интернэшнл Аг Application of calcium carbonate reacted on surface as carrier for agrochemical compounds
EP3045042A1 (en) 2015-01-15 2016-07-20 Omya International AG Use of surface-reacted calcium carbonate as carrier for agrochemical compounds
AU2016208111B2 (en) * 2015-01-15 2018-04-05 Omya International Ag Use of surface-reacted calcium carbonate as carrier for agrochemical compounds
WO2016113289A1 (en) 2015-01-15 2016-07-21 Omya International Ag Use of surface-reacted calcium carbonate as carrier for agrochemical compounds
US10292383B2 (en) 2015-01-15 2019-05-21 Omya International Ag Use of surface-reacted calcium carbonate as carrier for agrochemical compounds
WO2016146404A1 (en) 2015-03-16 2016-09-22 Omya International Ag Process for the purification of water
US10843932B2 (en) 2015-03-16 2020-11-24 Omya International Ag Surface-coated calcium carbonate-containing material and process for the purification of water
EP3070057A1 (en) 2015-03-16 2016-09-21 Omya International AG Process for the purification of water
WO2016150773A1 (en) 2015-03-20 2016-09-29 Omya International Ag Dispersible dosage form
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
US10617648B2 (en) 2015-03-20 2020-04-14 Omya International Ag Dispersible dosage form
US11041074B2 (en) 2015-12-01 2021-06-22 Omya International Ag Method for the production of granules comprising surface-reacted calcium carbonate
EP3176222A1 (en) 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3175835A1 (en) 2015-12-04 2017-06-07 Omya International AG Oral care composition for remineralisation and whitening of teeth
WO2017093002A1 (en) 2015-12-04 2017-06-08 Omya International Ag Oral care composition for remineralisation and whitening of teeth
EP3183965A1 (en) 2015-12-23 2017-06-28 Omya International AG Composition for aquatic pest control
EP3257501A1 (en) 2016-06-14 2017-12-20 Tillotts Pharma AG Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating
WO2017216088A1 (en) 2016-06-14 2017-12-21 Tillotts Pharma Ag Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating
US11400050B2 (en) 2016-06-21 2022-08-02 Omya International Ag Method for the production of a dosage form
CN109843053A (en) * 2016-10-21 2019-06-04 Omya国际股份公司 The purposes of supersaturated water-based system is used to prepare through surface reacting calcium carbonate
EP3311665A1 (en) 2016-10-21 2018-04-25 Omya International AG Use of surface-reacted calcium carbonate for preparing supersaturated aqueous systems
WO2018073040A1 (en) 2016-10-21 2018-04-26 Omya International Ag Use of surface-reacted calcium carbonate for preparing supersaturated aqueous systems
EP3599224A1 (en) 2018-07-24 2020-01-29 Omya International AG Particulate mineral materials functionalized with reducing agents for lowering the amount of heavy metal contaminants from an aqueous medium
EP3599016A1 (en) 2018-07-24 2020-01-29 Omya International AG Heavy metal removal using minerals being functionalized with thiols
WO2020020874A1 (en) 2018-07-24 2020-01-30 Omya International Ag Particulate mineral materials functionalized with reducing agents for lowering the amount of heavy metal contaminants from an aqueous medium
EP3599223A1 (en) 2018-07-24 2020-01-29 Omya International AG Heavy metal removal using minerals being functionalized with adsorption enhancers
WO2020020859A1 (en) 2018-07-24 2020-01-30 Omya International Ag Heavy metal removal using minerals being functionalized with adsorption enhancers
WO2020020715A1 (en) 2018-07-24 2020-01-30 Omya International Ag Heavy metal removal using minerals being functionalized with thiols
US12115258B2 (en) 2018-09-17 2024-10-15 Omya International Ag High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
US11617828B2 (en) 2019-07-17 2023-04-04 Medtronic Minimed, Inc. Reservoir connection interface with detectable signature
WO2021219529A1 (en) 2020-04-28 2021-11-04 Omya International Ag Method for the production of free-flowing granules
WO2021219458A1 (en) 2020-04-28 2021-11-04 Omya International Ag Granules comprising surface-reacted calcium carbonate as excipient
WO2022144403A1 (en) 2021-01-04 2022-07-07 Omya International Ag Delivery system for plant protection

Also Published As

Publication number Publication date
EP2331073A1 (en) 2011-06-15
JP2012504577A (en) 2012-02-23
AR073519A1 (en) 2010-11-10
US9757314B2 (en) 2017-09-12
US20120052023A1 (en) 2012-03-01
CN102170867A (en) 2011-08-31
AU2009299882A1 (en) 2010-04-08
US20160106639A1 (en) 2016-04-21
US20170340529A1 (en) 2017-11-30
CA2737395A1 (en) 2010-04-08
TW201014613A (en) 2010-04-16
US20170304165A1 (en) 2017-10-26
RU2502506C2 (en) 2013-12-27
US10137066B2 (en) 2018-11-27
US10045919B2 (en) 2018-08-14
UY32151A (en) 2010-04-30
CN102170867B (en) 2014-04-09
EP2168572A1 (en) 2010-03-31
KR20110061622A (en) 2011-06-09
RU2011117358A (en) 2012-11-10
KR101638643B1 (en) 2016-07-11
US9744107B2 (en) 2017-08-29
TWI453040B (en) 2014-09-21

Similar Documents

Publication Publication Date Title
US10137066B2 (en) Controlled release active agent carrier
US9579291B2 (en) Coated controlled release active agent carriers
CA2885971C (en) Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
EP2591772B1 (en) New coated controlled release active agent carriers
WO2016015812A1 (en) Directly compressible polyvinyl alcohols
TW201641120A (en) Dispersible dosage form
AU2009299882B2 (en) New controlled release active agent carrier
KR101507884B1 (en) Nano-concentrated capsule composition with water-soluble active material using thermal sensitive lipid-conjugated pluronic, manufacturing method thereof and cosmetic composition using the same
RU2203042C2 (en) Pharmaceutical composition and method for its preparing
Choya et al. Nanohybridization of biomolecules with layered double hydroxides and hydroxy double salts for advanced applications
RU2241451C1 (en) Pharmaceutical composition, its application and method for preparing
US20110021355A1 (en) Formulation with reduced hygroscopicity
RU2171673C1 (en) Pharmaceutical composition and method of its preparing
NZ623515B2 (en) New coated controlled release active agent carriers
UA61165C2 (en) Pharmaceutical composition and method for its production

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980138343.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09817294

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2737395

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009299882

Country of ref document: AU

REEP Request for entry into the european phase

Ref document number: 2009817294

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2009817294

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011529537

Country of ref document: JP

Ref document number: 627/MUMNP/2011

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2009299882

Country of ref document: AU

Date of ref document: 20090929

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20117008831

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2011117358

Country of ref document: RU

WWE Wipo information: entry into national phase

Ref document number: 12998060

Country of ref document: US